CLINICAL_TRIALS
trial_result
· 2023-04-21
Clinical Trial Update: A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD) [Phase 2]
Summary
Phase 2 PK and safety study of nemolizumab in adolescents with atopic dermatitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2023-04-21